DSM awarded Golden Peacock Environment Management Award 2014

DSM Sinochem Pharmaceuticals (DSP) Toansa wins special commendation for its efforts towards green chemistry and environmental compliance

mr

Mr Vineet Singhal CEO and Mr Rajesh Salwan, director-operations receiving the award.

DSM Sinochem Pharmaceuticals' Toansa facility has been awarded the "Special Recommendation" Golden Peacock Environment Management Award 2014 for its contribution and efforts towards green chemistry and environmental compliance by the Institute of Directors at a gala awards evening in Delhi. The plant is located in Toansa, Punjab, India.

DSM Sinochem Pharmaceuticals (DSP) is a global leader in enzymatically produced green beta-lactam antibiotics and next generation statins.
On receiving the award, Mr Vineet Singhal, business unit director (CEO) for Asia Pacific / Middle East / Africa at DSM Sinochem Pharmaceuticals said "DSM Sinochem Pharmaceuticals considers ‘Sustainability' a business driver and not just a social responsibility. We are fully committed to environmental protection via our innovative green products and best practices, which not only benefit the environment but also our customers and patients. This is a proud moment for us and we are delighted to receive this award. We have set a new benchmark in the industry through our continuous commitment and efforts towards sustainability via our green chemistry and environmental compliances."

The award was declared by the Awards Jury under the Chairmanship of Justice P N Bhagwati, former Chief Justice of India and Co-Chairmanship of Justice (Dr) Arijit Pasayat, former Judge, Supreme Court of India and former Chairman, Competition Appellate Tribunal of India and Authority for Advance Ruling (Customs, Central Excise and Service Tax).

DSM Sinochem Pharmaceuticals (DSP) is a joint venture between Royal DSM NV, a global science-based company active in health, nutrition and materials, and Sinochem, a global 500 fortune company with over 140 years of lineage in pharmaceuticals. DSP has its global headquarters in Singapore and caters to the global market through its five Business Units (BU), one of them being BU AMEA (Asia Pacific / Middle East / Africa). BU AMEA has its corporate office in Gurgaon and has its manufacturing facility located at Toansa in Punjab. DSP Toansa manufacturing unit manufactures Active Pharmaceutical Ingredients (APIs) in the Beta Lactams family and produces over 5500 MT of APIs. It is an Indian government initiative to stop the rampant usage of antibiotics, and DSP is an active partner with the state of Punjab in driving a campaign towards sustainable antibiotics.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

BusinessWire India.com - Pharmaceutical

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

BusinessWire India.com - Medical Devices

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X